SkinVision

Author: Anu

  • Why is skin cancer so common in Australia?

    —

    by

    Anu
    in

    Australia has a confluence of factors that put the population at risk of skin cancer. According to Cancer Council Australia, there are more than 750,000 people treated for one or more non-melanomas in Australia each year. Currently, two in three Australians will be diagnosed with some form of skin cancer before the age of 70.…

  • Milestone for SkinVision: Three Important Certifications Achieved

    —

    by

    Anu
    in

    SkinVision, the leading app for early skin cancer detection, recently achieved three important ISO certifications. The British Standards Institution (BSI), awarded SkinVision ISO 13485:2016 for its quality management system. Additionally, BSI awarded the company ISO 27001:2013 for information security management, as well as the Dutch national standard NEN 7510:2017, which includes additional requirements to ISO…

  • New Study Finds SkinVision Detects 95% of Skin Cancer 

    —

    by

    Anu
    in

    Amsterdam, 12 September 2019​ – An international group of researchers working with Erasmus University Medical Center (Erasmus MC) in the Netherlands determined that SkinVision – the first CE-marked skin cancer application based on extensive clinical trials – has a sensitivity of 95.1% in detecting the most common forms of skin cancer. 

  • SkinVision Joins the DigitalHealth.London Accelerator

    —

    by

    Anu
    in

    Smartphone App for Skin Cancer Risk Selected to Join DigitalHealth.London Accelerator SkinVision, a mobile application driving early skin cancer detection by empowering individuals to monitor their skin for early signs of skin cancer, has been selected to join the DigitalHealth.London Accelerator. 

  • Press Release: 3.6M CZ policyholders offered the SkinVision Service

    —

    by

    Anu
    in

    Dutch Health Insurer CZ and SkinVision partner to create an impact in early skin cancer detection

  • SkinVision to Join NHS Innovation Accelerator

    —

    by

    Anu
    in

    App empowering people to monitor themselves for early signs of skin cancer selected to join NHS Innovation Accelerator SkinVision, An app which empowers people to monitor themselves for early signs of skin cancer is one of four new technologies supporting earlier diagnosis and prevention of cancer, selected to join the NHS Innovation Accelerator.

  • What is the Chickenpox Vaccine?

    —

    by

    Anu
    in

    The vast majority of you reading this article, whether you remember it or not, will have gone through the itchy agony of chickenpox. Many of us have been left with scars from spots our parents couldn’t quite stop us itching, but not all children and parents today need to experience chickenpox distress. This is due…

  • Plasma Pen: Can I safely remove my moles at home?

    —

    by

    Anu
    in

    A new innovative kind of cosmetic treatment is currently used to remove small moles, the plasma pen.

  • How to use SkinVision

    —

    by

    Anu
    in

    This video quickly lays our how to use SkinVision, to ensure that you can make the most of the program. The SkinVision service is used by over a million people across the globe and has helped in the recognition of over 27,000 skin cancers. It is our aim to save 250,000 lives in the next…

  • Generali and SkinVision Offer New Service for Skin Cancer Screening in Germany

    —

    by

    Anu
    in

    For about two decades, the number of skin cancers across Europe has been rising steadily.  Every year more than 200,000 people in Germany are diagnosed with the disease – and the trend is rising. The earlier skin cancer is detected, the higher the chances of patient survival. To counteract the rising numbers, SkinVision has partnered…